Companies:
53,593
Total Market Cap:
173025940653892.34
NeuroSense Therapeutics Ltd.
NASDAQ: NRSN
Healthcare
Biotechnology
Global Rank
#41017
Country Rank
#514
Market Cap
12.84 M
Price
0.347
Change (%)
4.58%
Volume
233,415
NeuroSense Therapeutics Ltd.'s latest marketcap:
12.84 M
As of 09/12/2026, NeuroSense Therapeutics Ltd.'s market capitalization has reached $12.84 M. According to our data, NeuroSense Therapeutics Ltd. is the 41017th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 12.84 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -11,125,000 |
| Shares Out | 36.97 M |
| EPS (ttm) | -0.44 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/22/2026 |
Market Cap Chart
Data Updated: 09/12/2026
NeuroSense Therapeutics Ltd.'s yearly market capitalization.
NeuroSense Therapeutics Ltd. has seen its market value drop from $26.49 M to $12.84 M since 2021, representing a total decrease of 51.54% and an annual compound decline rate (CAGR) of 14.29%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 09/12/2026 | $12.84 M | -45.07% | 41017 |
| 12/31/2025 | $22.84 M | -17.7% | 27606 |
| 12/31/2024 | $27.75 M | 158.68% | 32007 |
| 12/29/2023 | $10.73 M | -24.68% | 36800 |
| 12/30/2022 | $14.24 M | -46.24% | 34375 |
| 12/31/2021 | $26.49 M | 31301 |
Company Profile
NeuroSense Therapeutics Ltd. was founded in 2017 in Israel.
The company went public on 12/09/2021
on the Nasdaq Stock Market.
With 17 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is NeuroSense Therapeutics Ltd.'s (NRSN) current market cap?As of 09/12/2026, NeuroSense Therapeutics Ltd. (including the parent company, if applicable) has an estimated market capitalization of $12.84 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does NeuroSense Therapeutics Ltd. (NRSN) rank globally by market cap?NeuroSense Therapeutics Ltd. global market capitalization ranking is approximately 41017 as of 09/12/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.